High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. (Record no. 11768373)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01886 a2200517 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250514024249.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200204s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0269-2813 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1046/j.1365-2036.2002.01173.x |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Peitz, Ulrich |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20020423 |
245 00 - TITLE STATEMENT | |
Title | High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Alimentary pharmacology & therapeutics |
Date of publication, distribution, etc. | Feb 2002 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 315-24 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Amoxicillin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Bacterial Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Ulcer Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Breath Tests |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clarithromycin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Helicobacter Infections |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Helicobacter pylori |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nitroimidazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Omeprazole |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sulliga, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wolle, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Leodolter, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Von Arnim, U |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kahl, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stolte, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Börsch, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Labenz, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Malfertheiner, P |
773 0# - HOST ITEM ENTRY | |
Title | Alimentary pharmacology & therapeutics |
Related parts | vol. 16 |
-- | no. 2 |
-- | p. 315-24 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1046/j.1365-2036.2002.01173.x">https://doi.org/10.1046/j.1365-2036.2002.01173.x</a> |
Public note | Available from publisher's website |
No items available.